Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction
Oscar Bartulos, … , Jordan S. Pober, Yibing Qyang
Oscar Bartulos, … , Jordan S. Pober, Yibing Qyang
Published July 7, 2016
Citation Information: JCI Insight. 2016;1(10):e80920. https://doi.org/10.1172/jci.insight.80920.
View: Text | PDF
Research Article Cardiology Neuroscience Stem cells Transplantation Vascular biology

ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction

  • Text
  • PDF
Abstract

Cardiovascular progenitor cells (CPCs) expressing the ISL1-LIM–homeodomain transcription factor contribute developmentally to cardiomyocytes in all 4 chambers of the heart. Here, we show that ISL1-CPCs can be applied to myocardial regeneration following injury. We used a rapid 3D methylcellulose approach to form murine and human ISL1-CPC spheroids that engrafted after myocardial infarction in murine hearts, where they differentiated into cardiomyocytes and endothelial cells, integrating into the myocardium and forming new blood vessels. ISL1-CPC spheroid–treated mice exhibited reduced infarct area and increased blood vessel formation compared with control animals. Moreover, left ventricular (LV) contractile function was significantly better in mice transplanted with ISL1-CPCs 4 weeks after injury than that in control animals. These results provide proof-of-concept of a cardiac repair strategy employing ISL1-CPCs that, based on our previous lineage-tracing studies, are committed to forming heart tissue, in combination with a robust methylcellulose spheroid–based delivery approach.

Authors

Oscar Bartulos, Zhen Wu Zhuang, Yan Huang, Nicole Mikush, Carol Suh, Alda Bregasi, Lin Wang, William Chang, Diane S. Krause, Lawrence H. Young, Jordan S. Pober, Yibing Qyang

×

Figure 8

Human ISL1-CPC spheroid–derived cells in infarcted hearts.

Options: View larger image (or click on image) Download as PowerPoint
Human ISL1-CPC spheroid–derived cells in infarcted hearts.
(A) Biolumine...
(A) Bioluminescence (BLI) imaging recorded in 1 mouse at 3 different time points after left anterior coronary artery ligation and human ISL1-CPC spheroid injection. Graph shows BLI quantification at 72 hours, 2 weeks, and 4 weeks after cell delivery. n = 8. Statistical analysis performed with 1-way repeated measurements ANOVA with Greenhouse-Geisser correction (P = 0.14). (B) Explanted heart 4 weeks after surgery and human ISL1-CPC spheroid injection showing BLI in the peri-infarct area. LV, left ventricle; RV, right ventricle. In A and B, the numbers in the scale bars were introduced manually to enlarge the font size. (C and D) Histological analysis of a heart, 4 weeks after MI. (C) Human ISL1-CPC spheroids differentiated into CMs in the midst of the scar. The white rectangle indicates the area shown in the magnified image displayed below. Scale bars: 50 μm (top panels) and 20 μm (bottom panels). (D) Human ISL1-CPC spheroids differentiated into functional blood vessels. The images marked by the numbers in the middle and bottom panels represent the magnified area demarcated by the rectangles in the top panels. HLA, human leukocyte antigen, which marks human ISL1-CPC–derived cells. Scale bars: 50 μm (top panels) and 20 μm (middle and bottom panels). (E) M-Mode fractional shortening recorded along the mid-left ventricular short axis, and B-Mode ejection fraction recorded along the parasternal long axis of mice subjected to ligation of the left coronary artery. Matrigel injection and human ISL1-CPC spheroid injection (n = 8 mice). Note that Matrigel-injected animals included six mice used in mouse ISL1-CPC studies. Three measurements were averaged per animal for each time point to obtain the M-Mode data. Samples were analyzed by 2-way ANOVA and pair comparisons using unpaired 2-tailed Student’s t test between groups (*P < 0.05), as well as pair comparisons for time points (2–3 days vs. 4 weeks) within the same group using paired 2-tailed Student’s t test (††P < 0.01; †††P < 0.001). See also Supplemental Figure 5, B and C, and Figures 6 and 7.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts